Depression Clinical Trials

911 recruiting

Understanding Depression Clinical Trials

While SSRIs like fluoxetine (Prozac) and sertraline (Zoloft) have been mainstay treatments for decades, clinical trials have recently delivered breakthrough therapies including esketamine (Spravato), the first rapid-acting antidepressant nasal spray, and brexanolone (Zulresso) for postpartum depression. Psilocybin-assisted therapy and novel glutamate modulators are advancing through trials with promising results. For the estimated one-third of patients whose depression does not respond adequately to standard antidepressants, clinical trials represent a vital pathway to new treatment options.

Why Consider a Clinical Trial?

Depression affects people differently, and no single treatment works for everyone. Approximately 30 to 40 percent of patients do not achieve adequate relief from first-line antidepressants, a condition known as treatment-resistant depression. For these individuals, clinical trials offer access to novel mechanisms of action that work differently from traditional serotonin-based medications, including drugs targeting glutamate, GABA, opioid, and inflammatory pathways. Even for patients whose depression responds to current treatments, trials are studying ways to achieve faster onset of relief (days instead of weeks), fewer side effects (particularly sexual dysfunction and weight gain), and longer-lasting remission. Participation in a depression trial includes comprehensive psychiatric monitoring, regular symptom assessments with validated scales, and close follow-up that can provide a higher level of care than routine outpatient treatment.

Frequently Asked Questions

Common questions about Depression clinical trials

Some trials allow you to continue your current medication, particularly augmentation studies that add a new treatment on top of your existing regimen. Others require a washout period to accurately assess the new treatment. Any medication changes are done gradually under close medical supervision to minimize withdrawal effects.

Your mental health is closely monitored throughout the trial with regular psychiatric assessments and standardized symptom rating scales. If your depression significantly worsens, the study team will intervene promptly, which may include adjusting treatment, providing rescue medication, or withdrawing you from the trial to ensure your safety.

Yes. Many trials test non-medication approaches including transcranial magnetic stimulation (TMS), psychotherapy techniques, digital therapeutics, exercise interventions, and neuromodulation devices. These trials are particularly relevant for patients who prefer non-pharmacological options or have not tolerated medications well.

Treatment-resistant depression is generally defined as depression that has not improved after trying at least two different antidepressants at adequate doses for adequate durations. Many trials specifically seek these patients, as they represent the population with the greatest unmet need. Your treatment history will be carefully reviewed during screening.

Clinical trial participation is protected by strict confidentiality rules. Your employer will not be notified. Insurance may see routine care claims but not the details of your trial participation. The study drug and research procedures are billed to the sponsor, not your insurance. Discuss any privacy concerns with the study team.

Showing 1–20 of 911 trials

Depression Clinical Trials

Understanding Depression Clinical Trials

Why Consider a Clinical Trial?

Frequently Asked Questions

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

Adjunctive Bright Light Therapy in Adolescents With Depression and Eveningness

IMST for Dementia Risk Reduction

Get ActivE Study for At-risk Youth

Low Frequency Right Dorsolateral Pre Frontal Cortical Repetitive TMS for Bipolar Depression

Acute Psychiatric Care at Home for Lower-risk Patients With Acute Psychiatric Illness Who Require Inpatient Care

Cerebellar Stimulation and Cognitive Control

Theta-Burst Stimulation for Bipolar Depression

TDM-Guided Treatment With SSRIs in Hospitalized Adults and Children

Aromatherapy for Mental Health Promotion in IVF Patients

CAPABLE Transplant

The Effects of High-dose Vitamin B6 on Depression and Anxiety Symptoms

Treating Depression on a Day-to-day Basis: Development of a Tool for Physicians Based on a Smartphone Application

Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)

Readiness and Progress in Emotion Regulation Therapy

PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)

Characterizing Dopamine Receptor Binding in Treatment Resistant Depression

Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease

Disruptions of Brain Networks and Sleep by Electroconvulsive Therapy

A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.